MBX Biosciences

Recent news

• Company notice
  4: MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Pescovitz Ora H.
  SEC · 2026/6/5
• Truist Financial Maintains MBX Biosciences(MBX.US) With Buy Rating
  Market Newswire · 2026/7/16
• Rating change
  MBX Biosciences, Inc. (MBX) Gets a Buy From Mizuho Securities
  TipRanks · 2026/8/8
• Company notice
  MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Hawryluk P. Kent
  SEC · 2026/5/9
• Guggenheim Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $150
  Market Newswire · 2026/10/2
• Rating change
  Stifel Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $70
  Market Newswire · 2026/8/13
• Rating change
  Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)
  TipRanks · 2026/8/7
• Company notice
  4: MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Hoerter Steven L.
  SEC · 2026/8/4
• Rating change
  Barclays Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $88
  Market Newswire · 2026/8/7
• Rating change
  LifeSci Capital Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $121
  Market Newswire · 2026/8/7
• Rating change
  Mizuho Securities Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $91
  Market Newswire · 2026/8/8
• Rating change
  UBS Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $90
  Market Newswire · 2026/7/24
• J.P. Morgan Maintains MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $88
  Market Newswire · 2026/8/21
• Company notice
  MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Hoerter Steven L.
  SEC · 2026/5/4
• Company notice
  4: MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Hoerter Steven L.
  SEC · 2026/6/5
• MBX Biosciences Insiders Added US$1.06m Of Stock To Their Holdings
  Simply Wall St · 2026/8/25
• Rating change
  Mizuho Securities Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $91
  Market Newswire · 2026/7/29
• Rating change
  LifeSci Capital Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $121
  Market Newswire · 2026/8/8
• Rating change
  Analysts Offer Insights on NA Companies: MBX Biosciences, Inc. (MBX), Septerna, Inc. (SEPN) and Six Flags Entertainment Corporation (FUN)
  TipRanks · 2026/8/13
• Truist Financial Maintains MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $88
  Market Newswire · 2026/8/10

Headlines are aggregated automatically and are not independently verified or edited by our team.